Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients

Renal Failure

Volumn 24, Issue 6, 2002, Pages 825-837

  Borawski, Jacek ^a   Pawlak, Krystyna ^a   Naumnik, Beata ^a   Myśliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hemodialysis patients; Hepatocyte growth factor; Liver disease; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; SCATTER FACTOR;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; LIPID OXIDATION; LIVER DISEASE; LIVER FUNCTION; MALE; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE INJURY; VIRUS HEPATITIS;

AGED; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREE RADICAL SCAVENGERS; HEPATITIS, VIRAL, HUMAN; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY DISEASES; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE;

EID: 0036441342     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120015684     Document Type: Article

References (33)

1. Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 2000, 29(3-4), 323-333.
2. Galle, J. Oxidative stress in chronic renal failure. Nephrol. Dial. Transplant 2001, 16(11), 2135-2137.
3. Boaz, M.; Green, M.; Fainaru, M.; Smetana, S. Oxidative stress and cardiovascular disease in hemodialysis. Clin. Nephrol. 2001, 55(2), 93-100.
4. Vargas, G.A.; Hoeflich, A.; Jehle, P.M. Hepatocyte growth factor in renal failure: Promise and reality. Kidney Int. 2000, 57(4), 1426-1436.
5. Kitta, K.; Day, R.M.; Ikeda, T.; Suzuki, Y.J. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic. Biol. Med. 2001, 31(7), 902-910.
6. Malatino, L.S.; Mallamaci, M.; Benedetto, F.A.; Bellanuova, I.; Cataliotti, A.; Tripepi, G.; Zoccali, C. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am. J. Kidney Dis. 2000, 36(5), 945-952.
7. Borawski, J.; Myśliwiec, M. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in hemodialysis patients. Nephrol. Dial. Transplant, 2002, 17, 637-644.
8. Rampino, T.; Arbustini, E.; Gregorini, M.; Guallini, P.; Libetta, C.; Maggio, M.; Ranghino, A.; Silini, E.; Soccio, G.; Dal Canton, A. Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor. Kidney Int. 1999, 56(6), 2286-2291.
9. Sommerburg, O.; Grune, T.; Hampl, H.; Riedel, E.; van Kujik, F.J.; Ehrich, J.H., Siems, W.G. Does long-term treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialyzed patients? Nephrol. Dial. Transplant 1998, 13(10), 2583-2587.
10. Boran, M.; Kucukakasu, C.; Balk, M.; Cetin, S. Red cell lipid peroxidation and antioxidant system in haemodialysed patients: Influence of recombinant human erythropoietin (r-HuEPO) treatment. Int. Urol. Nephrol. 1998, 30(4), 507-512.
11. Inal, M.; Kanbak, G.; Sen, S.; Akyuz, F.; Sunal, E. Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy. Free Radic. Res. 1999, 31(3), 211-216.
12. Kristal, B.; Shurtz-Swirski, R.; Shasha, S.M.; Manaster, J.; Shapiro, G.; Furmanov, M.; Hassan, K.; Weissman, I.; Sela, S. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients. Nephron 1999, 81(4), 406-413.
13. Ludat, K.; Sommerburg, O.; Grune, T.; Siems, W.G.; Riedel, E.; Hampl, H. Oxidation parameters in complete correction of renal anemia. Clin. Nephrol. 2000, 53(Suppl. 1): 30-35.
14. Herrera, J.; Nava, M.; Romero, F.; Rodriguez-Iturbe, B. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am. J. Kidney Dis. 2001, 37(4), 750-757.
15. Lim, P.-S.; Wei, Y.-H.; Yu, Y.-L.; Kho, B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol. Dial. Transplant 1999, 14(11), 2680-2687.
16. Mimic-Oka, J.; Simic, T.; Djukanovic, L.; Reljic, Z.; Davicevic, Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin. Nephrol. 1999, 51(4), 233-241.
17. Toborek, M.; Wasik, T.; Drózdz, M.; Klin, M.; Manger-Wróbel, K.; Kopieczna-Grzebieniak, E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992, 41(11), 1229-1232.
18. Hernandez de Rojas, A.; Mateo, M.C. Superoxide dismutase and catalase activities in patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis. Ren. Fail. 1996, 18(6), 937-946.
19. Emenaker, N.J.; DiSilvestro, R.A.; Nahman, N.S. Jr.; Percival, S. Copper-related blood indexes in kidney dialysis patients. Am. J. Clin. Nutr. 1996, 64(5), 757-760.
20. Weinstein, T.; Chagnac, A.; Korzets, A.; Boaz, M.; Ori, Y.; Herman, M.; Malachi, U. Haemolysis in haemodialysis patients: Evidence for impaired defense mechanisms against oxidative stress. Nephrol. Dial. Transplant 2000, 15(6), 883-887.
21. Nguyen-Khoa, T.; Massy, Z.A.; De Bandt, J.P.; Kebede, M.; Salama, L.; Lambrey, G.; Witko-Sarstat, V.; Drüeke, T.B.; Lacour, B.; Thévenin, M. Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol. Dial. Transplant 2001, 16(2), 335-340.
22. Shurtz-Swirski, R.; Mashiach, E.; Kristal, B.; Shkolnik, T.; Shasha, S.M. Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure. Nephron 1995, 71(2), 176-179.
23. Schettler, V.; Wieland, E.; Methe, H.; Schuff-Werner, P.; Muller, G.A. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol. Dial. Transplant 1998, 13(10), 2588-2593.
24. Schiaffonati, L.; Tiberio, L. Gene expression in liver after toxic injury: Analysis of heat shock response and oxidative stress-inducible genes. Liver 1997, 17(4), 183-191.
25. Broide, E.; Klinowski, E.; Koukoulis, G.; Hadzic, N.; Portmann, B.; Baker, A.; Scapa, E.; Mieli-Vargani, G. Superoxide dismutase activity in children with chronic liver disease. J. Hepatol. 2000, 32(2), 188-192.
26. Boya, P.; de la Pena, A.; Beloqui, O.; Larrea, E.; Conchillo, M.; Castelruiz, Y.; Civeira, M.P.; Prieto, J. Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J. Hepatol. 1999, 31(5), 808-814.
27. Par, A.; Roth, E.; Rumi, G. Jr.; Kovacs, Z.; Nemes, J.; Mozsik, G. Oxidative stress and antioxidant defense in alcoholic hepatitis and chronic hepatitis C. Orv. Hetil. 2000, 141(30), 1655-1659.
28. Fukai, T.; Galis, Z.S.; Meng, X.P.; Parthasarathy, S.; Harrison, D.G. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J. Clin. Invest. 1998, 101(10), 2101-2111.
29. Siwik, D.A.; Tzortzis, J.D.; Pimental, D.R.; Chang, D.L.; Pagano, P.L.; Singh, K.; Sawyer, D.B.; Colucci, W.S. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ. Res. 1999, 85(2), 147-153.
30. Nakajima, H.; Hangaishi, M.; Ishizaka, N.; Taguchi, J.; Igarashi, R.; Mizushima, Y.; Nagai, R.; Ohno, M. Lecithinized copper, zinc-superoxide dismutase ameliorates ischemia-induced myocardial damage. Life Sci. 2001, 69(8), 935-944.
31. Wang, X.L.; Adachi, T.; Sim, A.S.; Wilcken, D.E. Plasma extracellular superoxide dismutase levels in an australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1998, 18(12), 1915-1921.
32. Salvemini, D.; Wang, Z.-Q.; Zweier, J.L.; Samouilov, A.; Macarthur, H.; Misko, T.P.; Currie, M.G.; Cuzzocrea, S. Sikorski, J.A.; Riley, D.P. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999, 286(5438), 304-306.
33. Ferret, P.J.; Hammoud, R.; Tulliez, M.; Tran, A.; Trebeden, H.; Jaffray, P.; Malassagne, B.; Calmus, Y.; Weill, B.; Batteux, F. Detoxification of reactive species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001, 33(5), 1173-1180.